Aytu Biopharma

AYTU · NASDAQ

$2.01+$0.02 (+1.01%)TodayMarket closed ·
Prev close $1.99

Who owns AYTU

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 37.4% of AYTU’s shares.

  • Nantahala Capital Management, LLC10.1%
  • Stonepine Capital Management, LLC8.5%
  • AWM Investment Company, Inc.5.8%
  • Lytton (Laurence W)3.2%
  • Next 6 largest institutions9.9%
  • All other shareholders62.6%
Top institutional holders of AYTU
HolderShares% of shares
Nantahala Capital Management, LLC1.09M10.13%
Stonepine Capital Management, LLC912.92K8.51%
AWM Investment Company, Inc.619.57K5.77%
Lytton (Laurence W)338.34K3.15%
Vanguard Capital Management, LLC261.15K2.43%
Disbrow (Joshua R.)237.20K2.21%
Crown Advisors Management, Inc.200.00K1.86%
Diadema Partners LP148.55K1.38%
Two Sigma Investments, LP105.33K0.98%
Renaissance Technologies LLC104.82K0.98%

Largest mutual fund holders

Top mutual fund holders of AYTU
HolderShares% of shares
Vanguard Total Stock Market Index Fund169.00K1.58%
Vanguard Extended Market Index Fund92.15K0.86%
Fidelity Extended Market Index Fund48.91K0.46%
Perritt MicroCap Opportunitites Fund20.00K0.19%
Fidelity Series Total Market Index Fund14.10K0.13%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of AYTU in the last 6 months.

Latest AYTU insider transactions
InsiderTypeSharesValue
Disbrow Joshua R.Award30.00K—
PYSZCZYMUKA GREGAward20.00K—
Disbrow JarrettAward15.00K—
Selhorn Ryan JAward25.00K—
JAIN ABHINAVAward10.00K—
DOCKERY CARLAward10.00K—
Donofrio John Jr.Award10.00K—
LIU VIVIAN HAward10.00K—

Short interest

Settled Sep 30, 2026

Shares short
345.23K
Days to cover
4.74
% of shares outstanding
3.22%
Average daily volume
72.78K
Change since last report
+10.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.